Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant

Saved in:
Bibliographic Details
Main Authors: Karin Yaacoby-Bianu, Moshe Heching, Mordechai R. Kramer, Einat Shmueli, Dario Prais, François Vermeulen, Anabela S. Ramalho, Raya Cohen, Galit Livnat, Michal Shteinberg
Format: Article
Language:English
Published: European Respiratory Society 2025-01-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/11/1/00386-2024.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849772616069414912
author Karin Yaacoby-Bianu
Moshe Heching
Mordechai R. Kramer
Einat Shmueli
Dario Prais
François Vermeulen
Anabela S. Ramalho
Raya Cohen
Galit Livnat
Michal Shteinberg
author_facet Karin Yaacoby-Bianu
Moshe Heching
Mordechai R. Kramer
Einat Shmueli
Dario Prais
François Vermeulen
Anabela S. Ramalho
Raya Cohen
Galit Livnat
Michal Shteinberg
author_sort Karin Yaacoby-Bianu
collection DOAJ
format Article
id doaj-art-b9b990e093db4764b25bcccbeaf2063a
institution DOAJ
issn 2312-0541
language English
publishDate 2025-01-01
publisher European Respiratory Society
record_format Article
series ERJ Open Research
spelling doaj-art-b9b990e093db4764b25bcccbeaf2063a2025-08-20T03:02:16ZengEuropean Respiratory SocietyERJ Open Research2312-05412025-01-0111110.1183/23120541.00386-202400386-2024Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variantKarin Yaacoby-Bianu0Moshe Heching1Mordechai R. Kramer2Einat Shmueli3Dario Prais4François Vermeulen5Anabela S. Ramalho6Raya Cohen7Galit Livnat8Michal Shteinberg9 Pediatric Pulmonology Unit and CF Center, Carmel Medical Center, Haifa, Israel Pulmonology Institute and CF Center, Rabin Medical Center, Petah Tiqva, Israel Pulmonology Institute and CF Center, Rabin Medical Center, Petah Tiqva, Israel Pediatric Pulmonology Institute and CF Center, Schneider Children's Medical Center, Petah Tiqva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel CF Research Lab, Woman and Child Unit, Department of Development and Regeneration, KU Leuven, Leuven, Belgium CF Research Lab, Woman and Child Unit, Department of Development and Regeneration, KU Leuven, Leuven, Belgium B. Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel Pediatric Pulmonology Unit and CF Center, Carmel Medical Center, Haifa, Israel B. Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel http://openres.ersjournals.com/content/11/1/00386-2024.full
spellingShingle Karin Yaacoby-Bianu
Moshe Heching
Mordechai R. Kramer
Einat Shmueli
Dario Prais
François Vermeulen
Anabela S. Ramalho
Raya Cohen
Galit Livnat
Michal Shteinberg
Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant
ERJ Open Research
title Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant
title_full Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant
title_fullStr Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant
title_full_unstemmed Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant
title_short Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant
title_sort treatment effects of cftr modulators on people with cystic fibrosis carrying the q359k t360k variant
url http://openres.ersjournals.com/content/11/1/00386-2024.full
work_keys_str_mv AT karinyaacobybianu treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant
AT mosheheching treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant
AT mordechairkramer treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant
AT einatshmueli treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant
AT darioprais treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant
AT francoisvermeulen treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant
AT anabelasramalho treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant
AT rayacohen treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant
AT galitlivnat treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant
AT michalshteinberg treatmenteffectsofcftrmodulatorsonpeoplewithcysticfibrosiscarryingtheq359kt360kvariant